BioCentury
ARTICLE | Company News

Competitive Technologies, Beckman Coulter deal

August 1, 2005 7:00 AM UTC

CTT granted BEC a license to U.S. Patent No. 4,940,658 and its ex-U.S. counterparts covering homocysteine tests. CTT will receive a license fee and is eligible for royalties. ...